3,392 Shares in The Clorox Company (NYSE:CLX) Acquired by Radnor Capital Management LLC

Radnor Capital Management LLC acquired a new position in The Clorox Company (NYSE:CLX - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,392 shares of the company's stock, valued at approximately $553,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Fiduciary Family Office LLC purchased a new position in shares of Clorox in the third quarter worth $636,000. Yacktman Asset Management LP increased its holdings in Clorox by 1.0% in the 3rd quarter. Yacktman Asset Management LP now owns 31,400 shares of the company's stock valued at $5,115,000 after acquiring an additional 300 shares during the last quarter. Moloney Securities Asset Management LLC increased its holdings in Clorox by 11.9% in the 3rd quarter. Moloney Securities Asset Management LLC now owns 10,773 shares of the company's stock valued at $1,755,000 after acquiring an additional 1,144 shares during the last quarter. Catalyst Capital Advisors LLC purchased a new stake in Clorox in the 3rd quarter worth $54,000. Finally, QRG Capital Management Inc. bought a new position in shares of Clorox during the 3rd quarter valued at about $225,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Up 0.3 %

Shares of NYSE:CLX traded up $0.49 during trading hours on Thursday, hitting $163.19. 416,806 shares of the company's stock traded hands, compared to its average volume of 1,241,838. The firm has a market capitalization of $20.20 billion, a P/E ratio of 56.92, a price-to-earnings-growth ratio of 3.02 and a beta of 0.41. The business has a fifty day moving average price of $161.89 and a 200-day moving average price of $146.58. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $169.09. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company's quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.49 earnings per share. Equities analysts expect that The Clorox Company will post 6.81 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. Clorox's dividend payout ratio is 170.04%.

Insider Buying and Selling at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company's stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.57% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CLX. JPMorgan Chase & Co. lifted their target price on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a report on Friday, October 11th. Evercore ISI decreased their price objective on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a report on Monday, October 14th. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and increased their target price for the company from $155.00 to $170.00 in a research report on Wednesday. Citigroup boosted their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Finally, Jefferies Financial Group upgraded shares of Clorox from a "hold" rating to a "buy" rating and increased their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.